TRP Natural Eyes sterile eye drops recalled for lack of sterility assurance
TRP Natural Eyes Blur Relief eye drops are being recalled due to lack of assurance of sterility. The product was distributed to accounts in Rhode Island and Colorado.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves a risk-of-harm product with no reported illnesses or injuries. Sterile eye drops must meet strict standards, and lack of assurance of sterility poses a potential risk, meeting the High severity criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
TRP Natural Eyes Blur Relief (0.5 FL OZ/15 mL) is a homeopathic sterile eye drop product manufactured by AMMAN PHARMACEUTICAL INDUSTRIES in Jordan and distributed by TRP Company, Inc. (Reno, Nevada). The product is being recalled due to lack of assurance of sterility.
The recall affects 5,509 units with lot DC001 (expiration date 06/24). The product was distributed to two direct accounts in Rhode Island and Colorado.
The recalled product
- Product
- TRP Natural Eyes, Blur Relief, Sterile Eye Drops, Homeopathic 0.5 FL OZ (15 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-002-11.
- Manufacturer
- AMMAN PHARMACEUTICAL INDUSTRIES
- Category
- Drug — Ophthalmic / Eye Drops
- Hazard
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: DC001 EXP: 06/24
Distribution
Distributed in 2 states:
- CO
- RI
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27